Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive pressures in the vaccine market.
McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.